# Bundibugyo ebolavirus

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/bundibugyo-ebolavirus-company
Canonical HTML page: https://getyourbrief.com/entity/bundibugyo-ebolavirus-company

## Timeline

- **2026-08-04**: Leadership Visits and Latest Data Released — Africa CDC Director-General Jean Kaseya visited Bunia, WHO Director-General Tedros arrived in Kinshasa; government update reported 3,802 cases and 1,707 deaths.
- **2026-08-03**: Healthcare Workers Issue Ultimatum — In Mongbwalu, healthcare workers threatened to escalate action within 24 hours if unpaid wages were not resolved.
- **2026-07-05**: WHO reveals outbreak toll — WHO Director-General announces 1,400+ cases and 438 deaths, confirming the trial's start and expressing hope for effective therapies.
- **2026-07-02**: Trial launch and first enrollment — Researchers begin the first-ever Ebola treatment trial for Bundibugyo virus at Bunia's Evangelical Medical Center, enrolling the first participant to evaluate remdesivir and MBP134.
- **2026-06-15**: Uganda Declared Ebola‑Free — Neighboring Uganda discharged its last Ebola patient, ending its own transmission chain linked to the Congo outbreak.
- **2026-05-15**: Outbreak Declared — Eastern Congo Ebola outbreak officially declared, later linked to Bundibugyo virus.

## Recent coverage (3 stories, network-wide)

### As Ebola Deaths Top 1,700, Biotech Races for Bundibugyo Virus Treatments
2026-08-04 15:58:13 · Sector: bio · Sentiment: Strongly negative · Impact: 8/10 · Sources: 6

Congo’s Bundibugyo Ebola outbreak has surged to 3,802 cases and 1,707 deaths, highlighting an urgent need for vaccines and treatments. With no approved products available, two post‑exposure prophylaxis trials in Ituri and two vaccine trials in the UK and Canada are now underway, while nearly 80% of new cases elude contact tracing.
Full story: https://getbiobrief.com/story/ebola-deaths-top-1700-bundibugyo-virus-trials

### Congo Ebola Trial Enrolls First Patient Amid 438 Deaths
2026-07-25 17:51:47 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 1

A WHO-backed clinical trial in conflict-hit Congo is testing remdesivir and MBP134 for the Bundibugyo strain, spotlighting the extreme operational challenges of providing care and conducting research in fragile health systems.
Full story: https://gethealthbrief.com/story/congo-ebola-trial-health-systems

### Bundibugyo Ebola Outbreak Hits 2,181 Cases with No Vaccine, No Treatment
2026-07-25 03:00:49 · Sector: bio · Sentiment: Negative · Impact: 7/10 · Sources: 4

The fastest-growing Ebola outbreak in history is driven by the Bundibugyo virus, which lacks any approved vaccine or therapy. With over 2,100 cases and 864 deaths, biopharma companies face a pressing unmet need and a potential market for rapid filovirus countermeasure development.
Full story: https://getbiobrief.com/story/ebola-bundibugyo-vaccine-gap

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.